Kidney Transplant Recipients with Functioning Grafts for More than 15 Years

Basit Öğe Kaydı
dc.contributor.authorCeltik, A.
dc.contributor.authorAlpay, N.
dc.contributor.authorCelik, A.
dc.contributor.authorSezer, T. O.
dc.contributor.authorTurkmen, A.
dc.contributor.authorCamsari, T.
dc.contributor.authorToz, H.
dc.contributor.authorSever, M. S.
dc.contributor.authorHoscoskun, C.
dc.date.accessioned2019-10-27T21:52:29Z
dc.date.available2019-10-27T21:52:29Z
dc.date.issued2013
dc.departmentEge Üniversitesien_US
dc.description9th Congress of the Turkish-Transplantation-Centers-Coordination-Association (TTCCA) -- SEP 26-29, 2012 -- Bursa, TURKEYen_US
dc.description.abstractBackground. Renal transplantation is the best renal replacement therapy because it significantly improves patient survival. The developments in transplantation and increasing number of patients with end-stage renal disease (ESRD) have unmasked long-term complications secondary to immunosuppressive drugs and chronic renal failure. Methods and Results. Eighty-six renal transplant recipients with grafts that have functioned more than 15 years were included in the study. This cross-sectional retrospective analysis of demographic, clinical, and laboratory findings was conducted in 3 Turkish transplantation centers. The mean age was 30.4 +/- 10.2 years at the time of the transplantation. The mean time between the transplantation and the study was 19.1 +/- 3.6 years. At the time of the study, mean creatinine level was 1.52 +/- 0.60 mg/dL, 70.09% of the patients displayed glomerular filtration rates <60 mL/min/1.73 m(2). Urinary protein excretion was 0.57 +/- 0.65 g/d. Hypertension and hyperlipidemia were the most common comorbid diseases. Twelve patients had diabetes and 9 cardiovascular disease. Seventeen patients had been diagnosed with skin and 5 with non-skin cancer. Conclusions. As the number of recipients with long-term functioning grafts increases, long-term complications become evident, particularly chronic renal failure. Survivors should be evaluated regularly and treated early for risk factors and complications to improve long-term graft and patient survival.en_US
dc.description.sponsorshipTurkish Transplantat Ctr Coordinat Assoc (TTCCA)en_US
dc.identifier.doi10.1016/j.transproceed.2013.02.051en_US
dc.identifier.endpage907en_US
dc.identifier.issn0041-1345
dc.identifier.issue3en_US
dc.identifier.pmid23622583en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage904en_US
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2013.02.051
dc.identifier.urihttps://hdl.handle.net/11454/47647
dc.identifier.volume45en_US
dc.identifier.wosWOS:000318457000015en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofTransplantation Proceedingsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleKidney Transplant Recipients with Functioning Grafts for More than 15 Yearsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu